Onstage at Emtech 2019: The longevity economy, explained.

Onstage at Emtech 2019: The longevity economy, explained.

For the first time in history, there are more older people than young ones in the world. Whether our rapidly aging population becomes a social and economic crisis, or an opportunity is entirely up to us. You might not be able to live forever, but here’s how to live healthier and be more productive as you grow older. Join me, David Rotman, MIT Technology Review’s Editor at Large, as I talk to:

—Joseph Coughlin, the director of MIT AgeLab, who will describe the business opportunities offered by the fastest growing group in the US—people who are 65 and older. Forget about your stereotypes of seniors and their limitations, Coughlin will tell us about this vibrant and dynamic market and how to target it. It all begins with redefining how we think about aging.

—Joan Mannick, is the founder of a biotech company that is testing the first drug that might effectively slow the aging process. If it works—and we’ll ask her about the latest results—it will change medicine, providing new treatments for the many illnesses related to aging.

I’m thrilled to have this opportunity, and I hope you will be able to join me and my colleagues at EmTech. Tickets for the event are available here.